Our results revealed that dentatin showed strong cell-growth inhibition against PC-3 (androgen receptor-negative; androgen-resistant) [29] and LNCaP (androgen receptor-positive; androgen-dependent) [30], implying that dentatin-induced apoptosis in prostate cancer cells is not dependent on androgen sensitivity of the cells. Here, AR is linked to prostate carcinoma.